Pharmaceuticals company Sanofi Consumer Healthcare India announced Q2FY26 results Revenue at Rs 2,339 million, a growth of 46%. Domestic Sales grew by 20%. Export Sales grew by more than 10X due to low base. Profit After Tax was up by 40%. Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India, said: “Our third-quarter results reflect the strength of our diversified portfolio driving sustained growth momentum this quarter. The domestic business demonstrates good performance, with exports providing additional impetus to revenue growth. All our voluntarily recalled products have successfully re-established their market presence within the year. Anchored in science and guided by purpose, we remain committed to making self-care simpler, more accessible and more effective for every consumer.” Result PDF